Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced it will host a live webcast ...
New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results